Innate Tumor Immunity, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Innate Tumor Immunity, Inc..The latest application filed is for "nlrp3 modulators".
- Innate Tumor Immunity, Inc. - Princeton NJ US
- INNATE TUMOR IMMUNITY, INC - Princeton NJ US
- Innate Tumor Immunity, INC. - Cambridge MA US
| Patent | Date |
|---|---|
| Nlrp3 Modulators App 20220289736 - Glick; Gary D. ; et al. | 2022-09-15 |
| Nlrp3 Modulators App 20220257587 - O'Malley; Daniel ; et al. | 2022-08-18 |
| NLRP3 modulators Grant 11,344,543 - O'Malley , et al. May 31, 2 | 2022-05-31 |
| Nlrp3 Modulators App 20220089571 - O'Malley; Daniel ; et al. | 2022-03-24 |
| Nlrp3 Modulators App 20220089566 - WATTERSON; SCOTT HUNTER ; et al. | 2022-03-24 |
| Nlrp3 Modulators App 20220087991 - Watterson; Scott Hunter ; et al. | 2022-03-24 |
| Nlrp3 Modulators App 20220089572 - Gavai; Ashvinikumar V. ; et al. | 2022-03-24 |
| SUBSTITUTED 4-AMINO-1H-IMIDAZO[4,5-c]QUINOLINE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION App 20210332040 - Lou; Sha ; et al. | 2021-10-28 |
| Nlrp3 Modulators App 20210317118 - ZHANG; Yong ; et al. | 2021-10-14 |
| Nlrp3 Modulators App 20210308123 - Zhang; Yong ; et al. | 2021-10-07 |
| Nlrp3 Modulators App 20210267964 - ZHANG; YONG ; et al. | 2021-09-02 |
| NLRP3 modulators Grant 11,072,612 - Glick , et al. July 27, 2 | 2021-07-27 |
| Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20210147467 - Glick; Gary ; et al. | 2021-05-20 |
| Compounds and compositions for treating conditions associated with sting activity Grant 10,961,270 - Glick , et al. March 30, 2 | 2021-03-30 |
| Cyclic dinucleotides for treating conditions associated with STING activity such as cancer Grant 10,723,756 - Glick , et al. | 2020-07-28 |
| Compounds And Compositions For Treating Conditions Associated With Sting Activity App 20200165288 - Glick; Gary ; et al. | 2020-05-28 |
| Nlrp3 Modulators App 20200157097 - Glick; Gary D. ; et al. | 2020-05-21 |
| Nlrp3 Modulators App 20200157096 - Glick; Gary D. ; et al. | 2020-05-21 |
| Nlrp3 Modulators App 20200129500 - O'Malley; Daniel ; et al. | 2020-04-30 |
| Cyclic dinucleotides for treating conditions associated with sting activity such as cancer Grant 10,604,542 - Glick , et al. | 2020-03-31 |
| NLRP3 modulators Grant 10,556,903 - Glick , et al. Feb | 2020-02-11 |
| NLRP3 modulators Grant 10,533,005 - Glick , et al. Ja | 2020-01-14 |
| NLRP3 modulators Grant 10,533,007 - Glick , et al. Ja | 2020-01-14 |
| Cyclic Dinucleotide Analogs For Treating Conditions Associated With Sting (stimulator Of Interferon Genes) Activity App 20190345191 - Glick; Gary D. ; et al. | 2019-11-14 |
| Nlrp3 Modulators App 20190127367 - Glick; Gary D. ; et al. | 2019-05-02 |
| Immune Cells Having Increased Immunity Or Resistance To An Immunosuppressive Cytokine And Use Of The Same App 20190064146 - Glick; Gary D. ; et al. | 2019-02-28 |
| Nlrp3 Modulators App 20190055236 - Glick; Gary ; et al. | 2019-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 